Intrexon (XON) Tops Q2 EPS by 5c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/6/2026

1. NVDA
2. PTC
3. PCVX
4. META
5. AMD
6. SPY
7. RXO
8. USO
9. MSFT
10. GOOGL

Go back to Intrexon (XON) Tops Q2 EPS by 5c

ZIOPHARM Reports Second-Quarter 2015 Financial Results and Recent Activities

August 10, 2015 4:15 PM EDT

BOSTON, Aug. 10, 2015 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) today announced financial results for the second quarter ended June 30, 2015, and provided an update on the company's recent activities.

"ZIOPHARM continues to make important headway, both in the lab and clinic, in the development of our novel gene and adoptive cell therapy programs and technologies," said Laurence Cooper, M.D., Ph.D., Chief Executive Officer of ZIOPHARM. "This includes advancement of several chimeric antigen receptor (CAR) and T-cell receptor (TCR) candidates toward the clinic, evolution of the Sleeping Beauty non-viral gene transfer platform,... More